RGEN

RGEN

Repligen Corp
Life Sciences Tools & Services
$134.67 -0.54% As of Feb 25, 1:22 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Weak EMA Structure Weighs on RGEN at $134.67

Bearish
Feb 25, 2026 at 1:22 AM • $134.67 (-0.54%)

Repligen Corp (RGEN) slipped 0.54% to $134.67 on February 25.

Key indicators suggest a bearish bias:

Momentum RSI at 31.8 is neutral but weakening. MACD is bearish (-6.65 vs signal -6.41).
Moving Averages Bearish EMA structure persists with price below the 9-day ($137.37) and 21-day ($143.49).
Volatility Bollinger Band width at 24.4% indicates normal volatility.

While EMAs remain bearish, the oversold RSI reading hints at potential support around $126.03.

Traders are watching $126.03 on the downside and $161.01 on the upside.

Technical Breakdown: RGEN Loses EMA Support at $134.65

Bearish
Feb 24, 2026 at 9:01 PM • $134.65 (-0.56%)

Technical Damage Mounts for RGEN at $135.40

Bearish
Feb 23, 2026 at 9:01 PM • $135.40 (-0.21%)

RGEN Faces Resistance as EMAs Turn Bearish

Bearish
Feb 22, 2026 at 8:30 AM • $135.68 (-1.13%)

RGEN Technicals Deteriorate at $135.68 Level

Bearish
Feb 21, 2026 at 2:09 AM • $135.68 (-1.13%)
Systematic technical analysis • Updated daily after market close

Discussion

Your comment has been verified and is pending approval. It will appear shortly.
Loading comments...
Leave a Comment
0/2000
Email verification required to prevent spam
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $134.67
Daily Change -0.54%
Sentiment Bearish
Sector Life Sciences Tools & Services
Last Updated Feb 25

Related Stocks

ILMN
ILMN
Illumina Inc
TMO
TMO
Thermo Fisher Scientific Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.